Even one more day without a cure for metastatic (stage 4) breast cancer (MBC) is one day too many when lives are at stake. MBC is the most advanced stage of the disease. Though there are treatments to extend life, there is no cure. That's why this year, Komen is going one step further to raise an extra $1 million to fund the first ever MBC Excellence in Research Award. This award will fund cutting-edge research that holds the greatest promise for new MBC treatments. Read more and listen to our podcast at the link in our bio.